Thyrotoxic Periodic Paralysis (TPP): A Comprehensive Review with Regional Insights from the Middle East

甲状腺毒性周期性麻痹症(TPP):一项综合性综述及来自中东地区的见解

阅读:4

Abstract

BACKGROUND: Thyrotoxic periodic paralysis (TPP) is a rare but potentially life-threatening cause of acute flaccid paralysis, characterized by hypokalemia in the setting of thyrotoxicosis and often misdiagnosed in emergency departments. METHODS: We conducted a narrative literature review of TPP in adults using major databases up to 31 October 2025, with a focus on clinical presentation, precipitants, diagnostic pitfalls, and management, and we synthesized Middle Eastern case data alongside global experience. RESULTS: TPP typically affects younger males and may be the first manifestation of hyperthyroidism. High-carbohydrate meals, strenuous exercise, and β-agonists are common triggers. Misdiagnosis as Guillain-Barré syndrome or other neuromuscular conditions is frequent, particularly when thyrotoxicosis is subtle. Middle Eastern reports suggest similar clinical patterns but highlight delayed recognition and variable access to thyroid testing. Early correction of hypokalemia, non-selective beta (β)-blockade, and definitive control of thyrotoxicosis are essential to prevent recurrences. CONCLUSIONS: An emergency department (ED)-focused approach that routinely considers TPP in acute flaccid paralysis, integrates rapid thyroid function testing, and follows structured potassium replacement and β-blocker protocols can reduce diagnostic delay and improve outcomes. Incorporating regional data may help tailor awareness campaigns and management pathways in Middle Eastern and other underrepresented settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。